Showing results (141-150 of 3,015) with videos related to
Sort By:
Pageof 302
Current Drug Targets|May 14, 2008
Hypoxia inducible factor-1 alpha, endothelial progenitor cells, monocytes, cardiovascular risk, wound healing, cobalt and hydralazine: a unifying hypothesisMichel R Hoenig, Cesario Bianchi, Frank W SellkeCurrent Drug Targets|April 25, 2025
Microwave-assisted Green Synthesis: An Approach for the Development of Anti-tubercular AgentsBiswa Mohan Sahoo, Prafulla Nandi, Dipika Rani Sahu, et al.Current Drug Targets|April 18, 2025
Quorum Sensing and its Inhibition in Pseudomonas aeruginosa: Molecular Targets and Mode of ActionDimple K Kachhadiya, John J GeorrgeCurrent Drug Targets|April 21, 2025
Recent Advances in Understanding the Role of PEST Sequence-Containing Proteins in Retinal NeovascularizationYuxi Du, Yalong DangCurrent Drug Targets|January 28, 2026
Mechanistic Approach to Ferroptosis in Cancer and Neurological DiseasesPranay Wal, Abhijeet Singh Jadaun, Rakesh Verma, et al.Current Drug Targets|October 11, 2003
The adenine nucleotide translocator: a new potential chemotherapeutic targetAnne-Sophie Belzacq, Catherine BrennerCurrent Drug Targets|May 9, 2013
Methotrexate: should we start using it in clinical practice?Pal Miheller, Lajos S Kiss, Michael Mandel, et al.Current Drug Targets|May 9, 2013
Differential scanning calorimetry as a tool to investigate the transfer of anticancer drugs to biomembrane modelMaria Grazia Sarpietro, Maria Lorena Accolla, Christian Celia, et al.Current Drug Targets|April 12, 2013
New insights into dietary supplements used in sport: active substances, pharmacological and side effectsMarijana Zovko Koncic, Michal TomczykCurrent Drug Targets|May 25, 2013
Hypoxia-inducible factor-1 (HIF-1): a potential target for intervention in ocular neovascular diseasesRamya Krishna Vadlapatla, Aswani Dutt Vadlapudi, Ashim K MitraPageof 302